Listed by the USPTO as KEOGH, MATTHEW R
Tech Center 1600 • Art Units: 1638 1663
This examiner grants 78% of resolved cases
KEOGH, MATTHEW R is a USPTO patent examiner in tech center 1600 and art unit 1638. The record reports 717 resolved cases, an allowance rate of 78.5%, and a median of 965 days to allowance. The interview lift is 14.4%, indicating that interviews may assist prosecution but do not dominate the measured outcome.
The leading companies are Pioneer Hi-bred International Inc., Inari Agriculture Technology Inc., and Syngenta AG. The leading firms are MCKEE, VOORHEES & SEASE, P.L.C., ARENTFOX SCHIFF LLP, and DENTONS US LLP. Counsel should emphasize technically precise written responses, use interviews for targeted clarification, and consider the recorded allowance timing when coordinating examination with research, product, or portfolio decisions.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19372398 | METHODS AND COMPOSITIONS FOR THE INTRODUCTION AND REGULATED EXPRESSION OF GENES IN PLANTS | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 19220291 | USE OF MORPHOGENIC FACTORS FOR THE IMPROVEMENT OF GENE EDITING | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 18167247 | SOYBEAN VARIETY 5PUDM32 | Final Rejection | PIONEER HI-BRED INTERNATIONAL, INC. |
| 18067345 | GENERATING MAIZE PLANTS WITH ENHANCED RESISTANCE TO NORTHERN LEAF BLIGHT | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 17760273 | CAS-MEDIATED HOMOLOGY DIRECTED REPAIR IN SOMATIC PLANT TISSUE | Final Rejection | PIONEER HI-BRED INTERNATIONAL, INC. |
| 17052320 | METHODS AND COMPOSITIONS FOR HOMOLOGY-DIRECTED REPAIR OF CAS ENDONUCLEASE MEDIATED DOUBLE STRAND BREAKS | Final Rejection | PIONEER HI-BRED INTERNATIONAL, INC. |
| 19041097 | SOYBEAN VARIETY | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 18495805 | VARIETY CORN LINE HID2388 | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18705253 | TRANSCRIPTION REGULATING NUCLEOTIDE SEQUENCES AND METHODS OF USE | Final Rejection | BASF Agricultural Solutions Seed US LLC |
| 18677865 | Soybean Cultivar 3284306 | Non-Final OA | Confluence Genetics, LLC |
| 19197017 | INIR20 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS | Non-Final OA | INARI AGRICULTURE TECHNOLOGY, INC. |
| 19078091 | INIR6 TRANSGENIC MAIZE | Non-Final OA | INARI AGRICULTURE TECHNOLOGY, INC. |
| 18481358 | INIR11 TRANSGENIC MAIZE WITH JUNCTION SEQUENCE DELETIONS | Final Rejection | INARI AGRICULTURE TECHNOLOGY, INC. |
| 18780938 | COMPOSITIONS AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS | Final Rejection | Altria Client Services LLC |
| 19303663 | METHODS AND COMPOSITIONS FOR THE MODIFICATION OF PLANTS | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 19283275 | PagPB GENE REGULATING NITROGEN ABSORPTION AND UTILIZATION IN ROOT SYSTEM OF WOODY PLANT AND APPLICATION THEREOF | Non-Final OA | Research Institute of Forestry, Chinese Academy of Forestry |
| 18704380 | HETERODIMERIC BENZALDEHYDE SYNTHASE, METHODS OF PRODUCING, AND USES THEREOF | Non-Final OA | Purdue Research Foundation |
| 19021762 | CANOLA HYBRID 22CN0178 | Non-Final OA | BASF Agricultural Solutions US LLC |
| 17555737 | Canola Hybrid Variety 9CN0103 | Non-Final OA | BASF Agricultural Solutions US LLC |
| 18737058 | METHOD TO INCREASE POLLEN FERTILITY | Final Rejection | Keygene N.V. |
| 18538893 | METHODS AND COMPOSITIONS FOR USE OF DIRECTED RECOMBINATION IN PLANT BREEDING | Final Rejection | Monsanto Technology LLC |
| 18377421 | COMPOSITIONS AND METHODS FOR TRANSFORMATION OF EMBRYO EXPLANT POPULATIONS | Non-Final OA | Monsanto Technology LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy78.5% of resolved applications examined by Matthew R Keogh were allowed (717 resolved cases), compared with 48.8% across Art Unit 1638 over the last five years.
This examiner's interview lift is +14.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Matthew R Keogh took 965 days on average from filing to allowance.
Matthew R Keogh examines applications in Art Unit 1638 in Tech Center 1600 (Biotechnology & Pharmaceuticals).